Coronary interventions A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial Asano T, Jin Q, Katagiri Y, Kogame N, Takahashi K, Chang C, Chichareon P, Wang C, Shi B, Su X, Fu G, Wu Y, Zhou X, Yuan Z, Wykrzykowska J, Piek J, Serruys P, Onuma Y, Chen Y December 20, 2018 | 10.4244/EIJ-D-18-00461
A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study Han Y, Liu H, Yang Y, Zhang J, Xu K, Fu G, Su X, Jiang T, Pang W, Chen J, Yuan Z, Li H, Wang H, Hong T, Liu H, Sun F, Allocco D, Zhang M, Dawkins K November 20, 2017 | 10.4244/EIJ-D-17-00271
Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study Chen Y, Hu S, Liu Y, Zhao R, Wang L, Fu G, He Q, Su X, Zheng Y, Qi X, Liu H, Wang J, Gao W, Wang M, Liu S, Zheng X, Ben He B, Yang P, Zhou S, Gao C, Qiu C November 20, 2012 | 10.4244/EIJV8I7A126
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019